GFVAX
Price
$15.74
Change
+$0.09 (+0.58%)
Updated
Oct 17 closing price
Net Assets
56.24M
RMFEX
Price
$61.89
Change
+$0.16 (+0.26%)
Updated
Oct 17 closing price
Net Assets
111.18B
Interact to see
Advertisement

GFVAX vs RMFEX

Header iconGFVAX vs RMFEX Comparison
Open Charts GFVAX vs RMFEXBanner chart's image
Goldman Sachs Focused Value A
Price$15.74
Change+$0.09 (+0.58%)
VolumeN/A
Net Assets56.24M
American Funds American Mutual R4
Price$61.89
Change+$0.16 (+0.26%)
VolumeN/A
Net Assets111.18B
GFVAX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
GFVAX vs. RMFEX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVAX is a Hold and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. GFVAX (56.2M). RMFEX pays higher dividends than GFVAX: RMFEX (1.46) vs GFVAX (1.01). GFVAX was incepted earlier than RMFEX: GFVAX (10 years) vs RMFEX (23 years). GFVAX (1.68) is less costly to investors than RMFEX (0.62). GFVAX is a more actively managed with annual turnover of: 85.00 vs. RMFEX (31.00). RMFEX has a lower initial minimum investment than GFVAX: RMFEX (250) vs GFVAX (1000). RMFEX annual gain was more profitable for investors over the last year : 5.28 vs. GFVAX (-5.73). RMFEX return over 5 years is better than : 59.52 vs. GFVAX (43.16).
GFVAXRMFEXGFVAX / RMFEX
Total Expense Ratio1.010.62163%
Annual Report Gross Expense Ratio1.680.62271%
Fund Existence10 years23 years-
Gain YTD2.60813.94119%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets56.2M111B0%
Annual Yield % from dividends1.011.4669%
Returns for 1 year-5.735.28-108%
Returns for 3 years28.6940.0972%
Returns for 5 years43.1659.5273%
Returns for 10 years77.8698.8479%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMY10.670.17
+1.62%
Astellas Pharma, Inc.
GZDIF0.02N/A
N/A
Grizzly Discoveries Inc.
CSGQF1.38N/A
N/A
Costain Group Plc
AWLRF0.50-0.04
-7.47%
Awale Resources Limited
TSYHY12.56-1.13
-8.25%
TravelSky Technology Ltd.